These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 19062081

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Effects on Walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE).
    Teixeira RS, Curi R, Maranhão RC.
    J Pharm Pharmacol; 2004 Jul; 56(7):909-14. PubMed ID: 15233870
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Uptake of lipid core nanoparticles by fragments of tissues collected during cerebral tumor excision surgeries: hypotheses for use in drug targeting therapy.
    Pereira ELR, Feio DCA, Tavares JPL, Morikawa NM, Deus DF, Vital CG, Tavares ER, Maranhão RC.
    J Neurooncol; 2022 Jul; 158(3):413-421. PubMed ID: 35612697
    [Abstract] [Full Text] [Related]

  • 46. Comparative pharmacokinetics and tissue distribution analysis of systemically administered 17-β-estradiol and its metabolites in vivo delivered using a cationic nanoemulsion or a peptide-modified nanoemulsion system for targeting atherosclerosis.
    Deshpande D, Kethireddy S, Gattacceca F, Amiji M.
    J Control Release; 2014 Apr 28; 180():117-24. PubMed ID: 24556419
    [Abstract] [Full Text] [Related]

  • 47. Tumor vascular heterogeneity and the impact of subtumoral nanoemulsion biodistribution.
    de Oliveira JV, Oliveira da Rocha MC, de Sousa-Junior AA, Rodrigues MC, Farias GR, da Silva PB, Bao SN, Bakuzis AF, Azevedo RB, Morais PC, Muehlmann LA, Figueiró Longo JP.
    Nanomedicine (Lond); 2022 Nov 28; 17(27):2073-2088. PubMed ID: 36853205
    [Abstract] [Full Text] [Related]

  • 48. Perspectives of Nanoemulsion Strategies in The Improvement of Oral, Parenteral and Transdermal Chemotherapy.
    Pandey M, Choudhury H, Yeun OC, Yin HM, Lynn TW, Tine CLY, Wi NS, Yen KCC, Phing CS, Kesharwani P, Bhattamisra SK, Gorain B.
    Curr Pharm Biotechnol; 2018 Nov 28; 19(4):276-292. PubMed ID: 29874994
    [Abstract] [Full Text] [Related]

  • 49. Intralesional lipolysis with phosphatidylcholine for the treatment of lipomas: pilot study.
    Kopera D, Binder B, Toplak H.
    Arch Dermatol; 2006 Mar 28; 142(3):395-6. PubMed ID: 16549726
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The role of acoustofluidics and microbubble dynamics for therapeutic applications and drug delivery.
    Kaykanat SI, Uguz AK.
    Biomicrofluidics; 2023 Mar 28; 17(2):021502. PubMed ID: 37153864
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Lipid core nanoparticles resembling low-density lipoprotein and regression of atherosclerotic lesions: effects of particle size.
    Freitas SCMP, Tavares ER, Silva BMO, Meneghini BC, Kalil-Filho R, Maranhão RC.
    Braz J Med Biol Res; 2018 Jan 23; 51(3):1-8. PubMed ID: 29513883
    [Abstract] [Full Text] [Related]

  • 55. Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancer.
    Vohra T, Kaur I, Heer H, Murthy RR.
    Cancer Nanotechnol; 2013 Jan 23; 4(1-3):1-12. PubMed ID: 26069497
    [Abstract] [Full Text] [Related]

  • 56. Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.
    Mello SB, Tavares ER, Bulgarelli A, Bonfá E, Maranhão RC.
    Int J Nanomedicine; 2013 Jan 23; 8():443-9. PubMed ID: 23439784
    [Abstract] [Full Text] [Related]

  • 57. Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer.
    Pires LA, Hegg R, Freitas FR, Tavares ER, Almeida CP, Baracat EC, Maranhão RC.
    Braz J Med Biol Res; 2012 Jun 23; 45(6):557-64. PubMed ID: 22570085
    [Abstract] [Full Text] [Related]

  • 58. Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemotherapy.
    Mendes S, Graziani SR, Vitório TS, Padoveze AF, Hegg R, Bydlowski SP, Maranhão RC.
    Gynecol Oncol; 2009 Feb 23; 112(2):400-4. PubMed ID: 19062081
    [Abstract] [Full Text] [Related]

  • 59. Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study.
    Pires LA, Hegg R, Valduga CJ, Graziani SR, Rodrigues DG, Maranhão RC.
    Cancer Chemother Pharmacol; 2009 Jan 23; 63(2):281-7. PubMed ID: 18365196
    [Abstract] [Full Text] [Related]

  • 60. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers.
    Dias ML, Carvalho JP, Rodrigues DG, Graziani SR, Maranhão RC.
    Cancer Chemother Pharmacol; 2007 Jan 23; 59(1):105-11. PubMed ID: 16699792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.